Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
about
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemiaA subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyExpression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsMulti-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemiaIntegrative Analysis of MicroRNA-Mediated Gene Signatures and Pathways Modulating White Blood Cell Count in Childhood Acute Lymphoblastic Leukemia.Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia.A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemiaEvaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaPediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia.NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cellsElucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli.Towards targeted therapy for infant acute lymphoblastic leukaemia.Relationship between triterpenoid anticancer drug resistance, autophagy, and caspase-1 in adult T-cell leukemia.The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia.Antileukemic drug effects in childhood acute lymphoblastic leukemia.Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.PKCζ and PKMζ are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity.Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.Flow cytometric chemosensitivity assay using JC‑1, a sensor of mitochondrial transmembrane potential, in acute leukemia.Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cellsThe long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).A facile, branched DNA assay to quantitatively measure glucocorticoid receptor auto-regulation in T-cell acute lymphoblastic leukemiaThe novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells.Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.Inflammasome-mediated glucocorticoid resistance: The receptor rheostat.Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia.Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia.Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia.Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.
P2860
Q24597084-FB4ED4F7-910D-48C8-B1CE-DC7C5EAA4408Q24651897-071D4045-F840-4E1C-9877-BC5D765BEC17Q24685883-0A472F83-A671-4347-A14F-77F3E09C7BF5Q28541556-AA62B777-5CDD-4DD1-A8D7-E62957EC3660Q33580638-EB4E4873-D3DE-42FF-A64C-7613CB798C71Q33909896-26C5D146-1CA1-4B7F-8CDE-9F6D80B15233Q34448969-69B38994-C12D-4198-BEAB-7EB42F3DE0B6Q34542996-FDEEA597-3CF1-4C53-BE31-FBD63287D0A4Q35040531-4C2FF58E-32E4-4DD7-8B45-CB9D86E1A927Q35162503-31E922FE-4CED-4DEA-BD34-44163A267010Q35665990-DA2B4C64-8E5C-41E4-AE92-065CB1510799Q35856573-EDECF402-D3C9-4E14-8F5F-1BC648A5921BQ35921471-AE3BFE90-FF63-46A1-A51B-8E480047DC8EQ36038158-98178257-F3B5-4FA1-B137-34331851949EQ36381561-B05FE6D3-0341-4662-91A9-923A0BFDA6B8Q36905364-66D3034F-D739-433B-852B-C85E6AF80A54Q37090821-AFA1BAB6-A245-4ADA-A366-0476A321C38DQ37416851-99757047-CB54-40A9-B0AC-BD9AEDF7A9B6Q38178315-691950EA-A36C-43F7-8C91-BD5E8A937E8FQ38298331-ADF92F53-A33F-46DE-9121-2899FD67BE76Q38345216-F8CF3505-423A-4C71-8362-109A9DF4BA55Q38686308-897B1E2B-2C4C-4B8F-9B87-3FE5FE6F580FQ38796883-E4FD5B13-8ECF-4047-9D6F-887234FD7B78Q38978542-B0956089-048E-406F-8435-35142AB2C83EQ38999126-18820D3D-6879-49CF-AC94-3FC4B8FA8856Q39079802-4C43204D-743F-4D63-A77C-99602FA60C5DQ39108160-1C151B88-4D60-4DD2-8DB2-46EDC843788AQ39141522-215A150F-5F2B-490B-9C31-8D9F33D5E0C8Q39205653-BA787DFE-36B1-4622-B42F-FD4BF7062EB8Q39324129-4958A020-61A9-444E-8C53-A96F0AED9BB2Q39484177-3C41C1A9-188D-4AB5-98B6-7EBE29A3C026Q39918490-8C5690B8-5F1A-4B29-82EE-BC1FA19DD626Q40632365-1B65ED01-72EC-4F46-B02B-5FB84855EE93Q41872478-B6CCC8E7-731F-4D67-A446-EC17FF69C064Q42041565-CEBE28F7-E164-4EC7-8F3B-5CA486C3CAE7Q42127573-326380B8-A315-49CC-9905-213AE59D9F73Q42315787-52EAC23B-85E3-4F28-95F8-176C94547C7BQ42330161-5E6C0BCC-C086-4A4A-98B5-A5983B115A41Q42360020-33B78F5B-E0A0-411E-AB3A-D6C51408CDCBQ42547421-26972343-7052-46A1-9E77-EB4AA7363264
P2860
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Patient stratification based o ...... acute lymphoblastic leukemia.
@en
Patient stratification based o ...... acute lymphoblastic leukemia.
@nl
type
label
Patient stratification based o ...... acute lymphoblastic leukemia.
@en
Patient stratification based o ...... acute lymphoblastic leukemia.
@nl
prefLabel
Patient stratification based o ...... acute lymphoblastic leukemia.
@en
Patient stratification based o ...... acute lymphoblastic leukemia.
@nl
P2093
P356
P1476
Patient stratification based o ...... acute lymphoblastic leukemia.
@en
P2093
Den Boer ML
Graubner U
Janka-Schaub GE
Kaspers GJ
Kazemier KM
P304
P356
10.1200/JCO.2003.11.031
P407
P577
2003-09-01T00:00:00Z